Categories: Multiple Sclerosis


UCSF offers cautious recap but equates surrogate markers with clinical outcomes in MS drug study


NIH gives crisp summary of early stem cell transplants for multiple sclerosis, but missed some limitations


Do statistically insignificant outcomes in multiple sclerosis treatment study deserve a news release?

1 6/20/2016

Ottawa Hospital release on MS therapy hits the right notes with clarity and cautions


Data absent from claim that video game benefits MS patients


Engaging UCLA release suggests pregnancy hormone may benefit MS patients – but lacks key data

1 4/27/2015

Exaggeration at the NIH? Mouse study release may go too far in suggesting “reversal” of multiple sclerosis